rdf:type |
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0005682,
umls-concept:C0030705,
umls-concept:C0073081,
umls-concept:C0087111,
umls-concept:C0108303,
umls-concept:C0392747,
umls-concept:C0442124,
umls-concept:C0443172,
umls-concept:C0597879,
umls-concept:C1180419,
umls-concept:C1421309,
umls-concept:C1421467,
umls-concept:C1536696,
umls-concept:C2348042
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-3-30
|
pubmed:abstractText |
To compare PGP9.5 and transient receptor potential vanilloid receptor (TRPV1) suburothelial immunoreactivity between controls and patients with spinal neurogenic detrusor overactivity (NDO) before and after treatment with intravesical resiniferatoxin, as suburothelial PGP9.5-staining nerve fibres decrease in patients with spinal NDO who respond to intravesical capsaicin, and TRPV1 is present on these suburothelial nerve fibres in normal and overactive human urinary bladder.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Diterpenes,
http://linkedlifedata.com/resource/pubmed/chemical/Ion Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Neurotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Drug,
http://linkedlifedata.com/resource/pubmed/chemical/TRPV Cation Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Trpv2 protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/UCHL1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin Thiolesterase,
http://linkedlifedata.com/resource/pubmed/chemical/resiniferatoxin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1464-4096
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
93
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
770-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15049988-Administration, Intravesical,
pubmed-meshheading:15049988-Biological Markers,
pubmed-meshheading:15049988-Biopsy,
pubmed-meshheading:15049988-Diterpenes,
pubmed-meshheading:15049988-Double-Blind Method,
pubmed-meshheading:15049988-Humans,
pubmed-meshheading:15049988-Immunohistochemistry,
pubmed-meshheading:15049988-Ion Channels,
pubmed-meshheading:15049988-Middle Aged,
pubmed-meshheading:15049988-Neurotoxins,
pubmed-meshheading:15049988-Prospective Studies,
pubmed-meshheading:15049988-Receptors, Drug,
pubmed-meshheading:15049988-TRPV Cation Channels,
pubmed-meshheading:15049988-Ubiquitin Thiolesterase,
pubmed-meshheading:15049988-Urinary Bladder,
pubmed-meshheading:15049988-Urinary Bladder, Neurogenic,
pubmed-meshheading:15049988-Urinary Incontinence
|
pubmed:year |
2004
|
pubmed:articleTitle |
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.
|
pubmed:affiliation |
Department of Uro-Neurology, Institute of Neurology, Queen Square, London, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|